V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009343 | 270017827 | 1.62 | 87 | Curative (C) | 2014-10-05 | 2014-10-05 | Docetaxel 75mg/m2 (21 day) | N | N | 270017815 | CARBOPLATIN |
| 270009344 | 270005548 | 1.78 | 81 | Curative (C) | 2016-12-22 | 2016-12-29 | R ABVD | N | N | 270017821 | ABVD R |
| 270009345 | 270005548 | 1.7 | 57.5 | Curative (C) | 2013-03-18 | 2013-04-02 | CAPECITABINE + IRINOTECAN | 2 | N | 270017821 | CETUXIMAB + RT |
| 270009346 | 270015990 | null | 106 | Palliative (P) | 2015-07-21 | 2015-07-21 | Cetuximab + Oxaliplatin + MdG Maint | N | N | 270017826 | ECX |
| 270009347 | 270017828 | 1.65 | null | null | 2018-06-10 | 2018-06-13 | Bevacizumab 7.5mg/kg | null | null | 270017827 | BEVACIZUMAB |
| 270009348 | 270005549 | 1.82 | 59.7 | Neo-adjuvant (N) | 2016-12-19 | 2016-12-22 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270017834 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009349 | 270005549 | null | 84.4 | Adjuvant (A) | null | 2015-07-20 | Cetuximab + Radiotherapy Load | null | null | 270017834 | CARBOPLATIN + VINORELBINE |
| 270009350 | 270005549 | 1.75 | 85.8 | Adjuvant (A) | 2013-06-08 | 2013-06-09 | Bevacizumab + Cape + Oxali 21day | N | N | 270017834 | SCOT TRIAL |
| 270009351 | 270005550 | 1.85 | 125 | Curative (C) | 2016-12-07 | 2016-12-10 | CARBOPLATIN + RT | N | null | 270017863 | RALTITREXED |
| 270009352 | 270012754 | 1.74 | null | Curative (C) | 2013-01-10 | 2013-02-01 | METHOTREXATE | N | N | 270017864 | CHLORAMBUCIL |
| 270009353 | 270012754 | null | 77.7 | Palliative (P) | 2015-08-30 | 2015-09-17 | GemCarbo Days 1+8 | N | N | 270017864 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009354 | 270017829 | null | 46 | Palliative (P) | 2013-11-01 | 2013-11-15 | CARBOPLATIN + RT | N | N | 270017871 | CETUXIMAB + RT |
| 270009355 | 270017829 | null | 57.4 | Palliative (P) | 2018-01-09 | 2018-01-20 | Gemcitabine weekly | N | N | 270017871 | CAPE + CARBOPLATIN + CETUXIMAB |
| 270009356 | 270005551 | null | null | null | 2016-10-21 | 2016-10-30 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 270017881 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009357 | 270005552 | 1.59 | 58.4 | Not known (9) | 2013-04-29 | 2013-05-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 270017883 | CARBO + FLUOROURACIL |
| 270009358 | 270005553 | 1.77 | 77.2 | Palliative (P) | 2016-08-09 | 2016-08-20 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | null | 270017884 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009359 | 270005554 | 1.74 | null | Palliative (P) | 2015-03-20 | 2015-03-28 | Cetuximab + Radiotherapy Load | N | N | 270017888 | GEMCARBO |
| 270009360 | 270005555 | 1.8 | 72.2 | Neo-adjuvant (N) | 2016-12-08 | 2016-12-08 | CARBOPLATIN + RT | 2 | N | 270017893 | CARBOPLATIN |
| 270009361 | 270005555 | 1.69 | null | Neo-adjuvant (N) | 2017-01-01 | 2017-01-17 | Carbo F | Y | null | 270017893 | FOXTROT TRIAL |
| 270009362 | 270005556 | 1.8 | 50.1 | Curative (C) | 2017-06-24 | 2017-07-15 | Capecitabine + Cisplatin | N | N | 270017920 | CETUXIMAB + RT |
| 270009363 | 270005557 | 1.9 | 73.9 | Adjuvant (A) | 2015-11-05 | 2015-11-19 | CARBOPLATIN + RT | N | N | 270017928 | OXALIPLATIN |
| 270009364 | 270012756 | null | null | Curative (C) | 2014-11-06 | 2014-11-06 | CAP + RT | N | N | 270017933 | CETUXIMAB + RT |
| 270009365 | 270005558 | 1.77 | null | Neo-adjuvant (N) | 2014-04-08 | 2014-05-05 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270017938 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009366 | 270005559 | 1.8 | 125 | Curative (C) | 2015-04-23 | 2015-05-06 | FOXTROT TRIAL | N | N | 270017940 | CARBOPLATIN |
| 270009367 | 270012757 | 1.67 | 69.4 | Palliative (P) | 2014-04-23 | 2014-04-23 | CARBOPLATIN + RT | 99 | N | 270017950 | CARBOPLATIN + VINORELBINE |
| 270009368 | 270012757 | 1.62 | 83.5 | Curative (C) | 2015-10-14 | 2015-10-14 | CISPLATIN + VINORELBINE | N | N | 270017950 | CAPECITABINE + OXALIPLATIN + RT |
| 270009369 | 270012757 | 1.76 | null | Palliative (P) | 2017-05-13 | 2017-05-24 | Carbo F | N | Y | 270017950 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009370 | 270005560 | 1.74 | 75 | Curative (C) | 2014-09-15 | 2014-09-21 | CETUXIMAB | 02 | null | 270017983 | CARBOPLATIN + ETOPOSIDE |
| 270009371 | 270005561 | 0 | 70.9 | Curative (C) | 2015-11-27 | 2015-12-16 | CARBOPLATIN + RT | N | N | 270017987 | CETUXIMAB + RT |
| 270009372 | 270005562 | 1.89 | 79.8 | Palliative (P) | 2015-04-02 | 2015-04-02 | Carboplatin + Etoposide iv&po | 02 | N | 270017991 | BEVACIZUMAB + IRINOTECAN + MdG |
| 270009373 | 270005562 | 1.65 | 68.9 | Palliative (P) | 2016-06-07 | 2016-06-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | 270017991 | BEVACIZUMAB + CAPECITABINE |
| 270009374 | 270005563 | 1.78 | 80.9 | Adjuvant (A) | 2016-05-16 | 2016-10-05 | SCOT TRIAL | N | N | 270018040 | CETUXIMAB + OXALIPLATIN + MDG |
| 270009375 | 270012759 | 1.66 | 55.4 | Palliative (P) | 2014-10-17 | 2014-11-03 | DOCETAXEL + Prednisolone | N | N | 270018051 | EOX |
| 270009376 | 270005564 | 1.78 | 84.8 | Palliative (P) | 2016-10-19 | 2016-10-27 | IVE | 2 | N | 270018063 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009377 | 270005565 | 1.71 | 53.5 | Neo-adjuvant (N) | 2017-09-08 | 2017-10-18 | RUXOLITINIB | 02 | N | 270018064 | CARBOPLATIN + RT |
| 270009378 | 270012760 | 1.59 | 95 | Palliative (P) | 2015-04-24 | 2015-04-24 | SCOT TRIAL | N | N | 270018067 | CARBOPLATIN |
| 270009379 | 270005566 | 1.69 | 79.8 | Adjuvant (A) | 2015-02-05 | 2015-02-26 | CARBOPLATIN + RT | N | N | 270018086 | CETUXIMAB + RT |
| 270009380 | 270005567 | null | null | Palliative (P) | null | 2014-06-05 | CETUXIMAB + IRINOTECAN | null | null | 270018095 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009381 | 270005568 | 1.62 | 86 | Curative (C) | 2017-08-18 | 2017-09-03 | Cetuximab + Radiotherapy Maint | N | N | 270018100 | CARBOPLATIN |
| 270009383 | 270005570 | 1.53 | 49.9 | Curative (C) | 2016-07-27 | 2016-07-28 | Carboplatin + Vinorelbine IV | N | N | 270018110 | CAP + RT |
| 270009384 | 270005570 | null | 0 | Palliative (P) | null | 2016-03-17 | Carboplatin + Etoposide IV 3 day | N | N | 270018110 | CETUXIMAB + IRINOTECAN + MDG |
| 270009385 | 270005571 | 1.78 | 103.6 | Palliative (P) | 2017-07-03 | 2017-07-21 | Bevacizumab + Capecitabine | N | N | 270018134 | ENZALUTAMIDE |
| 270009386 | 270005572 | 1.73 | 51 | Curative (C) | 2014-02-25 | 2015-06-26 | CETUXIMAB + RT | N | N | 270018142 | CARBOPLATIN |
| 270009387 | 270005573 | 1.52 | 96.6 | Palliative (P) | 2017-09-24 | 2017-09-26 | Carboplatin + Pemetrexed | 2 | N | 270018154 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009388 | 270005574 | 1.63 | null | null | 2014-06-23 | 2014-07-01 | CARBOPLATIN + FLUOROURACIL | N | Y | 270018161 | CISPLATIN + VINORELBINE |
| 270009389 | 270005575 | 1.58 | 78.7 | Curative (C) | 2014-01-21 | 2014-02-04 | Cetuximab + Radiotherapy Load | 02 | N | 270018171 | FLUOROURACIL + MITOMYCIN + RT |
| 270009390 | 270005576 | 1.62 | 90 | Curative (C) | 2016-11-26 | 2016-12-04 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 270018177 | GEMCITABINE |
| 270009391 | 270005577 | 1.66 | 85.3 | Curative (C) | 2016-05-07 | 2016-05-23 | Cisplatin + Vinorelbine (PO) | N | N | 270018190 | CAPECITABINE + OXALIPLATIN + RT |
| 270009392 | 270005577 | null | null | Curative (C) | 2014-12-10 | 2014-12-10 | CARBOPLATIN + RT | N | N | 270018190 | CAP + RT |
| 270009393 | 270015994 | null | null | Palliative (P) | 2015-11-19 | 2015-12-01 | Cetuximab + Radiotherapy Load | 2 | N | 270018216 | CETUXIMAB |